Cosentyx (secukinumab) - Novartis
Clinical study of IL-17A inhibitors for improving scalp psoriasis (ChiCTR) - Oct 16, 2026 - P=N/A | N=30 | Not yet recruiting | Sponsor: First Affiliated Hospital of Kunming Medical University; First Affiliated Hospital of Kunming Medical University 
New trial • Dermatology • Immunology • Psoriasis
https://www.chictr.org.cn/showproj.html?proj=326336
 
Oct 16, 2026
 
Prev Next